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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORSpectrum of Biventricular Involvement on
CMR Among Carriers of ARVD/C-Associated
MutationsTABLE 1 Comparison Between Patients With Isolated RV
Abnormalities and Those With LV Abnormalities*
Abnormal
CMR
(n ¼ 38)
RV Only
Abnormality
(n ¼ 17)
LV*
Involvement
(n ¼ 21) p Value
Demographics
Age, yrs 39 (27–49) 43 (20–50) 28 (23–41) 0.088
Male 26 (68) 14 (82) 12 (57) 0.161
Proband 21 (55) 7 (41) 14 (67) 0.190
Deﬁnite ARVD/C at
last follow-up
34 (89) 15 (88) 19 (90) 0.770
PKP2 mutation carrier 28 (74) 16 (94) 12 (57) 0.012
Qualitative ﬁndings
RV WMA 34 (50) 16 (94) 18 (86) 0.613
RV fat 13 (34) 8 (47) 5 (24) 0.178
RV LGE 7 (18) 3 (18) 4 (19) 1.000
LV WMA 7 (18) — 7 (33) —
LV fat 16 (42) — 16 (76) —
LV LGE 18 (47) — 18 (86) —
Quantitative ﬁndings
RV ESVI, ml/m2 66  27 59  22 71  30 0.199
RV EDVI, ml/m2 105  33 98  28 109  36 0.343
RV EF, % 39  9 42  9 37  10 0.100
LV ESVI, ml/m2 41  12 39  11 42  13 0.434
LV EDVI, ml/m2 84  18 86  18 84  19 0.888
LV EF, % 52  7 54  7 50  7 0.144
CMR task force criteria
Any criterion 27 (68) 11 (65) 16 (76) 0.491
Major criterion 24 (60) 8 (47) 16 (76) 0.094
Minor criterion 3 (8) 3 (18) 0 (0) 0.081
Values are median (interquartile range), n (%), or mean  SD. *This group includes
subjects with biventricular involvement and LV-only involvement.
ARVD/C ¼ arrhythmogenic right ventricular dysplasia/cardiomyopathy; CMR ¼
cardiac magnetic resonance; EDVI ¼ end-diastolic volume indexed; EF ¼ ejection
fraction; ESVI ¼ end-systolic volume indexed; LGE ¼ late gadolinium enhance-
ment; LV ¼ left ventricle; PKP2 ¼ plakophilin-2; RV ¼ right ventricle; WMA ¼ wall
motion abnormality.Arrhythmogenic right ventricular dysplasia/cardio-
myopathy (ARVD/C) is a rare cardiomyopathy char-
acterized by myocardial ﬁbro-fatty replacement
predominantly affecting the RV. However, several
studies have demonstrated a high incidence of
biventricular or even isolated left ventricular (LV)
abnormalities (1,2). To date, the incidence and spec-
trum of biventricular abnormalities among ARVD/C
patients with pathogenic mutations and at-risk mu-
tation carriers is not well deﬁned in the North
American population. Therefore, our aim was to
evaluate the incidence and extent of biventricular
abnormalities on cardiac magnetic resonance (CMR)
in subjects with ARVD/C-associated mutations.
We identiﬁed 78 patients who had positive genetic
test for an ARVD/C-associated mutation and CMR. We
included affected, borderline, and unaffected (muta-
tion carriers) subjects as diagnosed by the 2010 Task
Force Criteria (TFC) (3). CMR exams were obtained on
1.5-T scanners and included double-inversion recov-
ery fast spin echo images, cine functional images, and
late gadolinium enhancement images. Quantitative
analysis was performed using QMASS (Medis, Leiden,
the Netherlands). Qualitative assessment was per-
formed by consensus of 3 expert readers. Each CMR
was scored for the presence of the CMR-speciﬁc TFC
as well for the presence of fatty inﬁltration and late
gadolinium enhancement of both ventricles. Loca-
tions of regional ﬁndings were recorded using an
anatomical 17-segment LV model and 5-segment RV
model (4). Continuous and categorical variables were
compared using the independent Student t test,
Fisher exact test, or Mann-Whitney U test, where
appropriate. Statistical analyses were performed us-
ing SPSS version 20 (IBM, Armonk, New York) and
STATA version 12 (Stata Corp., College Station, Texas).
All 78 subjects included carried a pathogenic
ARVD/C mutation (83% PKP2). Of those 78, 40 had
normal CMR exams. Among subjects with an
abnormal CMR, the majority (55%) had LV abnormal-
ities, of whom 19 of 21 (90%) had biventricular disease
and 2 (9%) had isolated LV abnormalities (Table 1).
Seventeen individuals had isolated RV involvement.
Comparing subjects with LV abnormalities (inclusiveof subjects with isolated LV or both LV and RV ab-
normalities), to those with isolated RV abnormalities,
there were no signiﬁcant differences in demographic,
qualitative, or quantitative ﬁndings in the RV or LV.
Subjects with isolated RV disease were signiﬁcantly
more likely to be plakophilin-2 (PKP2) mutation
carriers than patients with LV with or without RV
abnormalities (p ¼ 0.012). This difference was in part
driven by the isolated LV group (n ¼ 2), of whom
none carried a PKP2 mutation (1 DSP mutation car-
riers and 1 pln mutation carrier). Individuals with LV
abnormalities were equally as likely as those with
isolated RV involvement to meet either CMR TFC or
global TFC. Wall motion abnormalities were uncom-
mon and observed in only 7 subjects. Among the 21
subjects with LV abnormalities, LV size and function
were relatively preserved.
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864This study describes the spectrum of CMR ﬁndings
in a cohort of ARVD/C-associated mutation carriers,
including ﬁrst-degree relatives of ARVD/C patients
who were “at risk” of disease. Our study has several
important ﬁndings. First, in ARVD/C mutation car-
riers with structural disease on CMR, biventricular
abnormalities were seen with similar frequency to
isolated RV disease. Involvement of the LV in subjects
with ARVD/C has been increasingly recognized, with
prevalence reported in up to 80% of ARVD/C patients
in several European populations (1,2) and 40% in a
cohort of North American and Dutch patients (4). Our
study conﬁrms the high prevalence of biventricular
disease in North American patients with structurally
abnormal hearts and genetic predisposition to
ARVD/C. Interestingly, though, LV abnormalities
were not detrimental to cardiac function with no
signiﬁcant differences between groups with and
without LV involvement. Furthermore, demographic
and RV ﬁndings were similar between individuals
with isolated RV disease and those with biventricular
disease, suggesting that LV abnormalities may occur
at any stage of RV disease and are not limited only to
subjects with advanced RV disease. This ﬁnding ar-
gues against the traditional notion that LV abnor-
malities are a late complication of the disease (5).
More likely, there is a spectrum of the disease process
that varies from patient to patient, extending across
both ventricles. Finally, the only ﬁnding signiﬁcantly
different between subjects with isolated RV disease
and those with LV abnormalities was genotype, sug-
gesting an association between genotype and struc-
tural phenotype in ARVD/C mutation carriers.Neda Rastegar, MD
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Measurement in Healthy VolunteersTricuspid valve (TV) anatomy and function play an
important prognostic role in several heart diseases
and in the development of functional tricuspid
regurgitation. According to current guidelines for
management of heart valve disease, the tricuspid
annulus (TA) diameter measured by 2-dimensional
transthoracic echocardiography (2DE) should be used
to deﬁne the need of an associated TA annuloplasty
in patients undergoing cardiac surgery for left-sided
heart valve diseases (1,2). However, the timing dur-
ing the cardiac cycle when the TA should be measured
remains to be established. Moreover, normative data
about TA diameter and function are limited (3–5).
Therefore, we designed a prospective cross-
sectional study of 219 normal volunteers (age 43 
15 years; 57% female; body mass index <30 kg/m2)
to assess the variability of TA diameter measurement
in 2DE 4-chamber view (4CH) in relation to timing
during the cardiac cycle.
The TA diameter was obtained from the apical right
ventricular (RV)–focused 4CH using a Vivid E9 (GE
Vingmed, Horten, Norway) equipped with M5S probe
and measured as the distance between the insertion
points of the TV leaﬂets (inner edge to inner edge) at 5
time points during the cardiac cycle. The times during
the cardiac cycle were determined using both elec-
trocardiogram and valve dynamic visualization: TV
closure (end-diastole—the ﬁrst frame after the TV
closure), mid-systole (beginning of T-wave), end-
systole (end of T-wave), TV opening early ﬁlling (as
the frame with the TV wide open during passive ﬂow),
TV opening late ﬁlling (as the frame with the TV
wide open during active ﬂow—after P-wave).
